List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Macular Degeneration Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

List of Tables
Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2020*
Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2020*
Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2020*
Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures
Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2020*
Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2020*
Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
GlobalData Methodology

Companies Mentioned
- Novartis AG
- Bayer AG
- F. Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc
- Pfizer Inc
- Alcon Inc
- IVERIC bio Inc
- AbbVie Inc
- Novelion Therapeutics Inc
- Bausch Health Companies Inc